Blog Category: Consumer Protection

Since early 2020, consumers have faced countless shortages and supply chain disruptions throughout the economy, from personal protective equipment to infant formula to cars. Prescription medications are not exempt. In recent months, hospitals and other health care facilities have struggled to obtain sufficient stock of even basic supplies, such as saline, and national media outlets […]

Read More ›

At any given time, between 30,000 and 40,000 illegal online pharmacies hawk substandard prescription drugs to unsuspecting patients. Law enforcement and government agencies have a steep hill to climb in stopping them, but “lock-and-suspend” shows promise. Our newest Rogue Rx Activity Report explores how locking and suspending the domain names of these sites directly impacts […]

Read More ›

Of the examinations that NABP offers to gauge candidates’ readiness for pharmacy practice, the MPJE is the only one that assesses knowledge of state and federal laws and the ability to apply that knowledge in practice. We’ve heard of a misperception that a number of states are considering eliminating or have eliminated jurisprudence examinations for […]

Read More ›

As has been reported extensively over the past year, social media companies have come under scrutiny both at the national and international levels for not doing enough to prevent their platforms from being used to facilitate illegal drug sales. Despite reports that many popular platforms have stepped up efforts to police content – both TikTok […]

Read More ›

At the end of July, INTERPOL announced the execution of Operation Pangea XV, an annual week of coordinated law enforcement action to combat the illegal sale of medicines and medical products online. From June 23 to June 30, 2022, 94 member countries spanning every continent issued over 200 search warrants and opened over 600 investigations. […]

Read More ›

For over two decades, NABP has raised concerns over the vast number of illegal online pharmacies that put Americans’ health at risk by selling medications without a prescription, operating without a license, and peddling substandard, falsified, or counterfeit prescription drugs, including illicit opioids, to patients. Government agencies, including Food and Drug Administration (FDA), Drug Enforcement Administration (DEA), […]

Read More ›

In May, CDC revealed in provisional data that more people died of a drug overdose in 2021 than in any other year – 107,622. And the Journal of the American Medical Association reported in an April research letter that teens 14-18 experienced the largest jump in overdose deaths compared with the overall population.    Ed and […]

Read More ›

Congress has long had an interest in stemming the online sale of illegal opioids but investigating and identifying criminals who traffic these drugs on the dark web is incredibly challenging for law enforcement agencies. Enter the Dark Web Interdiction Act of 2022 (HR 7300, S 3782), a new bipartisan bill that seeks to improve the […]

Read More ›

If you follow us on social media, you might have noticed recent posts about our updated Facebook and Twitter consumer accounts, as well as our revamped patient-focused website. The changes are part of our larger campaign to empower patients with medication safety information and more directly highlight the efforts that we and our member boards […]

Read More ›

There is little argument among internet policy stakeholders that criminals do bad things on the internet. But that’s where the unity ends. Bickering continues over which of those bad things should be acknowledged as Domain Name System (DNS) abuse and, thus, who should be responsible for mitigating them (or not). For our part, call it […]

Read More ›